Status:
COMPLETED
Effects of Chinese Medicine on Early Pregnant Women
Lead Sponsor:
Shanghai Meiji Health Science and Technology Co., Ltd.
Collaborating Sponsors:
Shanghai Institute of Palnned parenthood research
Conditions:
Pregnant Women
Eligibility:
FEMALE
20-45 years
Brief Summary
From April 2021 to December 2021, 45 pregnant women who received intro fertilization-embyro transfer (IVF-ET) were recuited. According to their own wishes, 28 of them took Chinese medicine from the 2n...
Detailed Description
Investigators planned to performed a observational clinical trial to determine the effects of the Chinese medicine (Gushen Antai recipe) including mainly Rehmannia glutinosa used in pregnant women for...
Eligibility Criteria
Inclusion
- recieved IVF
- childbirth without miscarriage
- taking vitamins during pregnancy
Exclusion
- miscarrige
- missed sampling in the fourth week of pregnancy
- not appropriate judged by the doctor
Key Trial Info
Start Date :
May 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 2 2021
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT04848571
Start Date
May 1 2021
End Date
November 2 2021
Last Update
June 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Shanghai, China